ArticleDiabetes spectrum : a publication of the American Diabetes Association2018

Effectiveness and Tolerability of Therapy With Once-Weekly Exenatide Versus Basal Insulin Among Injectable-Naive Patients With Type 2 Diabetes in a Real-World Setting in the United States.

Anita M Loughlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.